ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect. The company is developing a bio-selected RNA virus to induce tumour inflammation and achieve immune cell infiltration via the RIG...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2019 (6 years)
Address:
HMRI BUILDING, 2 KOOKABURRA CIRCUIT; NEW LAMBTON HEIGHTS, NSW 2305, AU
LOW
spending power
